Skip to main content

Table 3 Biological parameters of Rhipicephalus sanguineus sensu lato ticks fed on immunized rabbits and control rabbits

From: Cross-species immunoprotective antigens (subolesin, ferritin 2 and P0) provide protection against Rhipicephalus sanguineus sensu lato

Groups

Nymphs

  

Engorgeda

Weightb

Moltingc

  

Control

31 ± 3.4

3.75 ± 0.13

26 ± 3

  

rSUB

19.3 ± 2.08 (37.6%*)

2.92 ± 0.05 (22%*)

12.33 ± 1.52 (52.5%*)

  

rFER2

16 ± 2.6 (48%*)

2.93 ± 0.08 (21.7%*)

9.33 ± 3.75 (64%*)

  

Cocktail

22.3 ± 2.08 (27%*)

3.11 ± 0.19 (17%*)

12.66 ± 1.54 (51%*)

  
 

Adult females

Engorgeda

Weightb

Egg layingd

Egg fertilitye

Total vaccine efficacyf

Control

5.33 ± 1.15

162.9 ± 13.1

0.56 ± 0.004

0.21 ± 0.035

 

rSUB

3 ± 0 (43.75%)

127.8 ± 5.17 (21.5%*)

0.26 ± 0.05 (53%*)

0.138 ± 0.089 (34.3%)

86.3%g

rFER2

3 ± 0 (43.75%)

124.1 ± 12.5 (23.8%*)

0.25 ± 0.03 (55%*)

0.104 ± 0.031 (50.4%*)

95.9%h

Cocktail

3.33 ± 0.5 (37.5%)

107.8 ± 23.3 (33.8%*)

0.32 ± 0.12 (43%*)

0.095 ± 0.018 (54.8%*)

90.9%h

  1. Values in table are presented as the mean ± standard deviation, with the reduction in percentage given in parentheses
  2. rFER2 Recombinant ferritin2; rPO recombinant partial 60S acidic ribosomal protein, rSUB recombinant subolesin
  3. *Significant difference from control at P-value < 0.05 was performed using Student's t-test
  4. aMean values for engorged nymphs and engorged female ticks fed on rabbits
  5. bMean values for weight (mg) of engorged nymphs and engorged female ticks
  6. cMolting capability
  7. dWhole egg weight per total female’s weight
  8. eWhole larvae weight per total egg weight
  9. fVaccine efficacy = 100 × [1 − (RN × VN × RA × OA × FE)], where RN, VN, RA, OA, and FE are mean values of the number of nymphs, molted nymphs, number of engorged females, egg weight and hatched larvae in the immunized group relative to that in the control group, respectively
  10. gSince the RA and FE were not significantly different in this group, these values were considered to be 0% of protection in the total vaccine efficacy formula
  11. hSince the RA was not significantly different in this group, this value was considered to be 0% of protection in the total vaccine efficacy formula